Internal Medicine · Lancaster, CA
NPI
1851616775
Since 2010
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
1600 W Avenue J
Lancaster, CA, 93534
Phone (626) 688-3568
Groups this clinician bills Medicare through
Medicare paid, 2024
$191K
2,237 services
Medicare patients, 2024
585
Average age 73
Drug cost, 2024
$937K
7,047 prescriptions
Company payments, 2025
$515
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Xiao H Wan was code 99233 (hospital e&m - subsequent), 677 times for 265 patients. In total Xiao H Wan billed 2,237 services in 47 codes, and Medicare paid $191K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 677 | 265 | $92.00 | $62K |
| 99223 Hospital E&M - Initial | Facility | 267 | 255 | $124.51 | $33K |
| 99239 Hospital Discharge Management | Facility | 208 | 198 | $90.38 | $19K |
| 93010 Electrocardiogram | Facility | 123 | 118 | $5.57 | $685 |
| 99497 Care Management/Coordination | Facility | 121 | 107 | $59.32 | $7,177 |
| 99214 Office E&M - Established | Office | 114 | 58 | $93.19 | $11K |
| 99309 SNF E&M | Facility | 109 | 37 | $83.17 | $9,066 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 102 | 48 | $13.53 | $1,380 |
| 99306 SNF E&M | Facility | 71 | 44 | $144.66 | $10K |
| 99491 Chronic, Principal, and Transitional Care Management | Facility | 70 | 27 | $59.53 | $4,167 |
| 99497 Care Management/Coordination | Office | 65 | 56 | $65.06 | $4,229 |
| 99215 Office E&M - Established | Office | 52 | 39 | $145.97 | $7,590 |
| 99491 Chronic, Principal, and Transitional Care Management | Office | 51 | 26 | $70.84 | $3,613 |
| 99213 Office E&M - Established | Office | 20 | 17 | $66.68 | $1,334 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 15 | 14 | $243.29 | $3,649 |
By year: 2022 $394K for 4,149 services; 2023 $667K for 6,845 services; 2024 $191K for 2,237 services.
Medicare prescription drug claims, 2024
In 2024, the drug Xiao H Wan prescribed most often to Medicare patients was Atorvastatin Calcium, with 302 prescriptions and refills. In total Xiao H Wan wrote 7,047 Medicare prescriptions that cost $937K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 302 | 550 | 124 | $3,388 |
| Amlodipine Besylate Generic | 259 | 512 | 96 | $1,765 |
| Furosemide Generic | 168 | 275 | 78 | $792 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 160 | 160 | 73 | $1,889 |
| Eliquis Apixaban | 149 | 183 | 55 | $80K |
| Levothyroxine Sodium Generic | 141 | 237 | 52 | $1,808 |
| Losartan Potassium Generic | 124 | 256 | 43 | $1,085 |
| Pantoprazole Sodium Generic | 123 | 180 | 58 | $2,031 |
| Hydralazine Hcl Generic | 113 | 152 | 52 | $1,121 |
| Metoprolol Succinate Generic | 111 | 225 | 46 | $1,848 |
| Gabapentin Generic | 110 | 159 | 54 | $1,445 |
| Metformin Hcl Generic | 106 | 203 | 39 | $1,059 |
| Metoprolol Tartrate Generic | 103 | 137 | 36 | $1,122 |
| Potassium Chloride Generic | 94 | 159 | 43 | $4,118 |
| Cephalexin Generic | 88 | 88 | 76 | $667 |
Brand drugs: 1,230 claims; generic drugs: 5,713 claims; opioid claims: 354.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Xiao H Wan $515 ($515 in general payments such as food, travel and fees) from 2 companies. The largest payer was ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) with $355.
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $355 |
| Novo Nordisk Inc NVO | 4 | $159 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.